Home Sectors Healthcare Valuation Today: Cantel Medical Corp. (NYSE: CMD)

Valuation Today: Cantel Medical Corp. (NYSE: CMD)


Cantel Medical Corp. trades as part of the medical instruments and equipment industry and is part of the healthcare sector. The company CEO is Jorgen B. Hansen. Cantel Medical Corp is dedicated in delivering infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.

Previous Intraday Trading Performance:

The CMD stock showed a previous change of 2.58% with an open at 83.13 and a close of 84.65. It reached an intraday high of 85.15 and a low of 83.11.

PR Newswire:  Cantel Completes Acquisition of Omnia S.p.A.


The stock has a market cap of $3.5b with 41.7m shares outstanding, of which the float is 36.7m shares. Trading volume reached 227,851 shares compared to its average volume of 183,550 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Cantel Medical Corp. shares returned 5.68% and in the past 30 trading days it returned 15.39%. Over three months, it changed 8.03%. In one year it has changed -26.02% and within that year its 52-week high was 130.92 and its 52-week low was 69.36. CMD stock is 22.05% above its 52 Week Low.

Our calculations show a 200 day moving average of 92.41 and a 50 day moving average of 78.41. Currently CMD stock is trading -8.40% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.

PR Newswire:  Cantel Completes Acquisition of Omnia S.p.A.


The last annual fiscal EPS for the company was reported at 2.19 that ended on 31st of July 2018, which according to the previous close, that is a PE of 38.65. Based on 1 analyst estimate, the estimated EPS for the next quarter is 0.62. The TTM EPS is 2.38, which comes to a TTM PE of 35.57. Historically, the PE high was 76.60 and the PE low was 27.10. If the stock reached its PE low, that would represent a price of 64.49, which is a decrease of -23.81%.

The following are the last four quarter reported earnings per share:
10-31-2018:  0.62
07-31-2018:  0.62
04-30-2018:  0.60
01-31-2018:  0.59

The dividend per share is currently 0.20, which is a dividend yield of 0.24%. Also, the payout ratio is 8.40%, therefore the dividend is safe according to our calculations.

Base on our calculations, the intrinsic value per share is 58.25, which means it may be overvalued by -45.33%

Indicators to Watch:

Based on the latest filings, there is 128.70% of institutional ownership. Short-interest is 1,312,973, which is 3.15% of shares outstanding. The short-interest ratio or days-to-cover ratio is 6.58. This stock has some short interest, but it may be normal and no cause for concern if long the position.

The current calculated beta is 1.19

PR Newswire:  Mack-Cali Announces Upcoming Changes to Board of Directors

Fundamental Indicators:

Based on last reported financials, the company’s return on equity is 15.14%, return on assets is 9.59%, profit margin is 8.34%, price-to-sales is 5.13 and price-to-book is 5.48.

Company Scores:

All scores are out of six:
 1  :Valuation Score
 3  :Past Performance Score
 5  :Financial Strength Score
 3  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.